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ABSTRACT
Genomic imprinting is an epigenetic process reg-
ulated by germline-derived DNA methylation that
is resistant to embryonic reprogramming, resulting
in parental origin-specific monoallelic gene expres-
sion. A subset of individuals affected by imprinting
disorders (IDs) displays multi-locus imprinting dis-
turbances (MLID), which may result from aberrant
establishment of imprinted differentially methylated
regions (DMRs) in gametes or their maintenance in
early embryogenesis. Here we investigated the extent
of MLID in a family harbouring a ZFP57 truncating
variant and characterize the interactions between hu-
man ZFP57 and the KAP1 co-repressor complex. By
ectopically targeting ZFP57 to reprogrammed loci in
mouse embryos using a dCas9 approach, we confirm
that ZFP57 recruitment is sufficient to protect oocyte-
derived methylation from reprogramming. Expres-
sion profiling in human pre-implantation embryos
and oocytes reveals that unlike in mice, ZFP57 is
only expressed following embryonic-genome activa-
tion, implying that other KRAB-zinc finger proteins
(KZNFs) recruit KAP1 prior to blastocyst formation.
Furthermore, we uncover ZNF202 and ZNF445 as ad-
ditional KZNFs likely to recruit KAP1 to imprinted
loci during reprogramming in the absence of ZFP57.
Together, these data confirm the perplexing link be-
tween KZFPs and imprint maintenance and highlight
the differences between mouse and humans in this
respect.
INTRODUCTION
Genomic imprinting in mammals refers to a highly-
coordinated epigenetic mechanism that leads to parental
allele-specific gene expression (1). Imprinted genes are
known to play critical roles in fetal development, placenta
and brain function, which when perturbed, result in im-
printing disorders (IDs) (2). The characteristic monoal-
lelic expression of imprinted genes is largely conferred
by allele-specific DNA methylation, referred to as differ-
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entially methylated regions (DMRs) that act as imprint-
ing control regions (ICRs). The differential DNA methy-
lation at the majority of ICRs is inherited from the ga-
metes and maintained in pre-implantation embryos dur-
ing global epigenetic reprogramming (3). The resulting
germline-derived DMRs (gDMRs) in general are ubiqui-
tously present in all tissues later in development, but a sub-
set have a tissue-specific profile, often restricted to the pla-
centa (4,5). In addition to gDMRs, a variety of mechanisms
ensure monoallelic expression of imprinted transcripts, in-
cluding somatically acquired DMRs (also known as sec-
ondary DMRs) and allele-specific histone modifications,
including H3K9me3 and H3K27me3 (6,7). Intriguingly, a
number of tissue-specific imprinted genes, whose temporal
imprinting is limited to cleavage stage embryos and pla-
centa, appear to utilize non-canonical mechanisms not as-
sociated with gDMRs but reliant on histone modifications
(8–10).
Gene encoding Kruppel-associated (KRAB)-zinc finger
proteins (KZFPs), which are involved in the establishment
and maintenance of repressive chromatin states, are highly
abundant in the mammalian genome (11). KZFPs have
classically been linked to the silencing of transposable
elements, with underlying sequence-specificity attributed
to unique combinations of zinc-finger that target different
retrotransposon families (12). Once recruited to a sequence,
transcriptional repression is mediated by the recruitment
of the KAP1 co-repressor complex, which induces the local
deposition and maintenance of H3K9me3 (13). KZFPs
have been shown not only to recognise transposable el-
ements, but an increasing number of these proteins also
bind to single-copy regions in the genome. One of the
most-studied members in this respect is ZFP57, which in
addition to Intracisternal A Particle (IAP) Long Terminal
Repeats (LTR) retrotransposons, also binds to imprinted
gDMRs (14–17). Because ZFP57 is highly abundant in
mouse oocytes and recognises methylated CpG dinu-
cleotides in the TGCCmeGC hexamer consensus motif, this
KZFP is largely responsible for maintaining methylation
at the majority of gDMRs during mouse pre-implantation
reprogramming (15,18,19). The high oocyte expression
of Zfp57 is consistent with it being a maternal-zygotic
effect gene in mice. When expression is depleted in zygotes
derived from heterozygous females (Zfp57 –/– offspring
from Zfp57+/– mothers) the severity of both methylation
defect and penetrance of the phenotype are less severe
than in homozygous nulls from Zfp57 –/– mothers (16).
Recessive mutations in the human orthologue causes
transient neonatal diabetes mellitus (TNDM) associated
with multi-locus methylation disturbance (MLID) (20),
a phenomenon in which loss-of-methylation (LOM)
at numerous imprinted DMRs is observed in addition
to the disease-associated loci (2). To date, 14 families
have been described with either missense or truncating
mutations in ZFP57 (21,22), all have a notably similar
methylation signature; complete hypomethylation of the
PLAGL1 DMR (PLAGL1:alt-TSS-DMR) and variable
combinations of mosaic hypomethylation at GRB10
(GRB10:alt-TSS-DMR), PEG3 (PEG3:TSS-DMR),
MEST (MEST:alt-TSS-DMR), NAP1L5 (NAP1L5:TSS-
DMR) and GNAS (GNAS-AS1:TSS-DMR). However,
whether ZFP57 can directly regulate those loci has not
been addressed.
In this study, we investigate the stability of mosaic hy-
pomethylation at imprinted DMRs in a family with a
ZFP57 truncatingmutation and characterize ZFP57-KAP1
functional interactions in humans. Furthermore, we iden-
tify additional KZFPs that are expressed at the appropri-
ate time during human development that have the ability to
recruit the KAP1. Together, these results shed light on the
species-specific function of ZFP57 in regulating imprinting
maintenance during development.
MATERIALS AND METHODS
Ethics
The family with the ZFP57p.E123* mutation provided in-
formed consent to be involved in this study. The eth-
ical approval for this aspect of the work was granted
by the Bellvitge Institute of Biomedical Research Ethics
Committee (PR096/10), the Basque Ethics Committee
(IRB#PI2013214 and PI2017018) and Hospital Universi-
tario La Paz (IRB-HULP PI446). Collecting placenta sam-
ples was approved by the Bellvitge Institute of Biomedical
Research Ethics Committee (PR006/08). The use of sur-
plus human oocytes and embryos for this study was eval-
uated and approved by the scientific and ethic committee of
the Instituto Valenciano de Infertilidad (IVI) (1310-FIVI-
131-CS), Centro de Medicina Regenerativa de Barcelona
(CMRB), the National Committee for Human Reproduc-
tion (CNRHA) and the Regional Health Departments for
Valencia and Catalyuna (10/2017). Ethical approval for the
using hES cells was granted by the Bellvitge Institute for
Biomedical Research Ethics Committee (PR096/10) and
Comites E´ticos de Investigacio´n Clı´nica (CEIC) del Centro
deMedicinaRegenerativa de Barcelona-CMR[B] (28/2012)
and complied with the legal guidelines outlined by the Gen-
eralitat de Catalunya and the Conselleria de Salut. Mouse
work was approved and performed under the authoriza-
tion of the Upper Bavarian authorities. Animal husbandry
and breeding were conducted according to the institutional
guidelines for the care and the use of laboratory animals.
Patient samples
A family with siblings diagnosed with TNDMwho were re-
ferred to the paediatric endocrinology at Carlos de Haya
Hospital (Malaga, Spain) were used in this study. The pre-
viously identified mutation was confirmed in proband II.2
using standard PCR and sequencing as described by Court
and colleagues (23). Two separate cohorts ofMLIDpatients
were screened for mutations, the first comprising of mainly
Beckwith–Wiedemann syndrome patients were from the
Spanish overgrowth registry (n = 28), while patients with
Pseudohypoparathyroidism type 1B (PHP1B; n = 10) and
TNDM (n = 3) were from the BioAraba Research Health
Institute. A collection of 15 human leukocyte and buccal
swabs were collected from volunteers at PEBC-IDIBELL
and used as controls to determine the normal range of
methylation at imprinted DMRs. Twelve humanmetaphase
II oocytes and a single surplus human blastocyst were ob-
tained from the Instituto Valenciano de Infertilidad (FIVI)
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(Valencia, Spain). Vitrified oocytes were thawed using a
kit for de-vitrification (Kitazato Valencia, Spain) following
manufacturer’s instructions.
Single cell lymphoblastoid colony expansion
Isolated clonal cell lines were generated by dilution plating
of a polyclonal lymphoblastoid cell as previously described
(24). Transformation with Epstein–Barr virus (EBV) was
performed on a fresh blood sample from patient II.1. Iso-
lated B-cells within the sample were immortalized with the
supernatant of the EVB producer cell line B95.8. Surviving
colonies were propagated to a density sufficient for DNA
isolation.
Methylation array hybridisation
Wegeneratedmethylation datasets for affected familymem-
bers with the ZFP57p.E123*mutation using the Illumina
Infinium HumanMethylation450 (HM450k) and Infinium
HumanMethylationEPIC (EPIC) BeadChip arrays. Bisul-
phite conversion of 600 ng of DNA was performed accord-
ing to the manufacturer’s recommendations for the Illu-
mina Infinium Assay (EZ DNA methylation kit, ZYMO,
Orange, CA, USA). The bisulphite-converted DNA was
used for hybridisation following the Illumina Infinium HD
methylation protocol at genomic facilities at IDIBELL
(Barcelona, Spain). In addition to these samples, we also
utilized our control leukocyte datasets from GSE103738
and GSE149572 (25).
Statistical analyses of the Illumina arrays
Raw data was normalised using the default control probes
in BeadStudio (version 2011.1) Infinium HD), subtracting
signal background and correcting for interpolate variation.
Probes with a detection P-value >0.01, containing SNPs
within the integration or extension bases as well as those
with potential cross-reaction due to multiple sequences ho-
mologies were discarded. Probes lacking signal values in
one or more of the analysed samples were discarded also.
For the analysis of known imprinted domains, probes map-
ping to the DMRs identified by Court et al. and Hernandez
Mora et al. were directly examined (25,26).
Allele-Specific bisulphite PCR
For standard bisulphite conversion, we used the EZ DNA
Methylation-Gold kit (ZYMO, CA, USA) according to
the manufacturer’s instructions. Approximately 2 l of
bisulphite-converted DNA was used in each amplifica-
tion reaction catalysed by Immolase Taq polymerase (Bi-
oline). The resulting PCR product was sub-cloned into
the pGEM-T easy vector (Promega) for sequencing (for
primer sequences see Supplementary Table S1). The EZ
DNAMethylation-Direct kit (ZYMO), in which cell lysates
are subject to direct bisulphite conversion, was used for the
methylation profiling of individual blastocysts and pooled
oocytes. Nested bisulphite PCR was required to obtain am-
plicons for sub-cloning due to the small amounts of avail-
able samples.
Pyrosequencing analysis for methylation quantification
Approximately 50 ng of bisulphite converted DNA was
used for PCR prior to pyrosequencing. Standard bisul-
phite PCR was used to amplify the imprinted DMRs with
the exception that one primer was biotinylated (see Sup-
plementary Table S1 for primer sequences). In all cases
the entire biotinylated PCR product (diluted to 40 l)
was mixed with 38 l of Binding buffer and 2 l (10
mg/ml) streptavidin-coated polystyrene beads. After wash-
ing in 70% ethanol, DNA was denaturated with 50 l 0.5M
NaOH. The single-stranded DNA was hybridized to 40-
pmol sequencing primers dissolved in 11l annealing buffer
at 80◦C. For sequencing, forward primers were designed
to the complementary strand. The pyrosequencing reaction
was carried out on a PyroMark Q96 instrument. The peak
heights were determined using Pyro Q-CpG1.0.9 software
(Biotage).
Nested multiplex bisulphite PCR
We employed a multiplex nested PCR approach to max-
imise data generation from individual mouse embryos
which were subject to direct bisulphite conversion. The pro-
tocol has been described elsewhere (27); essentially two sets
of primers (outer and inner pairs) were designed to each lo-
cus and robustly optimized to ensure efficient amplification
of bothmethylated and unmethylated strands at a single an-
nealing temperature without contamination or the forma-
tion of primer dimers (primers detailed in Supplementary
Table S1). For the multiplex step, outer primers (four sep-
arate pairs targeting different loci) were co-amplified in the
first reaction using Immolase Taq polymerase (Bioline) for
45 cycles. The multiplex PCR was carried in a total volume
of 97 l, including the 30 l of embryo converted DNA as
a template. We included two controls: blank with no sam-
ple and 10 ng of BS-converted DNA as a positive control.
The nested second round amplifications utilized the inter-
nal primer pairs specific for each region with individual
PCRs performed on aliquots of the first-round product. The
nested reaction was performed in a total volume of 25 l
reaction using Immolase Taq polymerase (Bioline). These
were amplified for 45 cycles and the resulting amplicons
used for pyrosequencing or sub-cloned into the pGEM-T
easy vector.
Single colony restriction enzyme-based analysis of methyla-
tion
To analyse the methylation state of four different regions in
the lymphoblastoid single colonies we performed a proto-
col similar to the one described by Cheow and colleagues
(28). After collecting the DNA of each of the clonal lym-
phoblastoid population, the DNA was digested with the
methylation-sensitive enzyme BstUI for 2 h at 37◦C in a
thermocycler. The digested DNA was subjected to ampli-
fication by PCR using primers flanking a restriction site in
the region of interest, and the methylation state was identi-
fied depending on the size of the amplicon, larger amplicons
were methylated and small amplicon resulted irrespective of
methylation status (primer sequences are detailed in Supple-
mentary Table S1).
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Genotyping and imprinting analysis
Potential SNPs in ZFP57 exons and hap-ASM were iden-
tified in the UCSC hg19 browser and genotyped by PCR
and direct sequencing in hES cell lines. Sequence traces were
interrogated using Sequencher v4.6 (Gene Codes Corpo-
ration, MI) to distinguish heterozygous and homozygous
samples. Heterozygous sample cell lines were analyzed for
allelic expression usingRT-PCRand bisulphite PCR, incor-
porating the polymorphism within the final PCR amplicon
(see Supplementary Table S1 for primer sequences).
Quantitative Real-Time-PCR
Expression of ZFP57 isoforms, ZNF202 and ZNF445
transcripts were analyzed using a fluorochrome (SYBR®
Green)-based quantitative real-time RT-PCR assay and
normalized against RPL19. cDNA was synthesized as pre-
viously described (29). All assays were run in triplicate in 96-
well or 384-well plates using Real-Time-PCR System (Ap-
plied Biosystems). Only samples with two or more valid
readings per triplicate were included in our analysis. Disso-
ciation curves were generated at the end of each reaction to
rule out the presence of primer-dimers or unexpected DNA
species in the reaction. Results were analyzed with the SDS
2.3 software (Applied Biosystems).
Antibodies
The primary antibodies used included -HA (Sigma
H6900; co-IP 5g;WB 1:1000), -FLAG (Sigma 180, 5g;
WB 1:1000 ChIP 5 g), -myc (Sant Cruz Biotech 9E10, 5
g;WB1:5000),-V5 (Bio-RadMCA1360, co-IP 5g;WB
1:1000) and -B actin (Sigma, A3854,WB 1:1000). The sec-
ondary antibodies used were -mouse (Sigma A9044) and
-rabbit (Sigma A0545)
Transfection, protein extraction and immunoprecipitation
All cell lines were grown inDMEM(Life Technologies) sup-
plemented by 10% fetal bovine serum (Life Technologies).
Cells were routinely tested for mycoplasm infection with
PCR- detection kit (Biotools-Biot. & Med). All transfec-
tions formammalian over-expressionwere carried out using
PEI reagent following supplier’s recommendations. Trans-
fections with Cas9 utilized OptiMEM media (Gibco) and
Lipofectamine 3000 (ThermoFisher) using recommended
protocols.
Nuclear and cytoplasm extract were prepared for
protein extraction to perform western blot and co-
immunoprecipitation assays. Cell were pelleted and washed
twice with cold PBS, and proteins were extracted according
to the Dignam protocol: first extraction for the cytoplasmic
soluble fraction was made with Buffer A (10 mM Tris pH
7.8; 10 mMKCl; 1.5 mMMgCl2) and second extraction for
the nuclear soluble fractionwasmadewithBuffer C (10mM
Tris pH 7.8; 0.42 MNaCl; 1.5 mMMgCl2; 0.2 mM EDTA;
25% glycerol). Extracts were kept at −80◦C until use.
For immunoprecipitation experiments, cell extracts were
incubated with either -HA resin or -FLAG, -V5 or -
Myc tag antibody crosslinked to protein G-magnetic beads
(ThermoFisher), overnight. Beads were washed three times
with BC100 buffer (10 mMTris pH 7.8, 0.5 mMEDTA, 0.1
mM phenylmethylsulfonyl fluoride, 0.1 mM dithiothreitol
(DTT), 10% glycerol, 100 mM KCl) and three times with
BC500 buffer (500 mM KCl). Then, proteins were eluted
with 0.2 M Glycine pH 2.3.
Western blotting
Protein extracts and co-IPs were mixed with 5× SDS load-
ing buffer (1 M Tris pH 7.8, 87% glycerol, 10% SDS and
0.1 g of bromophenol blue), and samples were boiled for 5
min at 95◦C. Samples were loaded on a gel alongwith 5l of
pre-stained PageRuler protein ladder (Fermentas) and run
at 25 mA. The gels were blotted with transfer buffer (Tris
0.25M, glycine 1.92 M and 1% SDS) on to nitrocellulose
membrane in a blotting chamber (Bio-Rad) for 45 min at
0.40 A. Successful transfer of proteins was confirmed by
Ponceau (Sigma) staining. Then, membrane was blocked
with 5% low fat milk (Merck) diluted in PBS-Tween for 1
h at room temperature. The membrane was subsequently
washed three times in PBS–Tween and incubated with the
primary antibody, in 5% low fat milk overnight at 4◦C on
a horizontal agitator. Afterwards, membrane was washed
three times for 5min with PBS-Tween, then the correspond-
ing peroxidase-conjugated secondary antibody was applied
in 5% low fat milk dilution 1:5000 for 1 h at room temper-
ature. The membrane was washed with PBS–Tween three
times more and placed on a developing machine.
Histone peptide array
MODified™Histone peptide Array (Active Motif) contain-
ing 384 different histone modification combinations was
used. The array was blocked overnight in 5% low fat milk
(Merck) diluted in TBS–Tween solution, followed by three
washes for 5 min with TBS–Tween and incubated overnight
in an orbital shaker with 6 M of the corresponding pu-
rified protein in TBS–Tween. The array was washed three
times in TBS–Tween and incubated with -HA primary an-
tibody, in 5% low fat milk for 3 h on a horizontal blocker at
4◦C. Following three more washes in TBS-Tween, -rabbit
peroxidase-conjugated secondary antibody was applied in
5% low fat milk dilution 1:2500 for 1 h at room tempera-
ture. Following three last washes in TBS–Tween the array
filters were develop and quantified.
dCas9-fusion plasmids, in vitro transcription, zygote microin-
jections and embryo culture
The dCas9-Zfp57[KRAB]-T2A-GFP fusion construct was
generated using the pLV hUbC-dCas9-VP64-T2A-GFP
plasmid backbone (30). The NheI sites were used to re-
move VP64 and introduce mouse ZFP57 (amino acids 13–
55 encoding the KRAB domain). We also generated the
control plasmid, dCas9-control, with no insert (Nhe1 self-
ligation). In vitro transcription (IVT) was utilized to gener-
ate full-length RNA for zygote injections using the mMES-
SAGE mMACHINE® T7 Ultra Kit (Thermofisher). The
IVT template was the PCR product generated using the
dCas9-Zfp57[KRAB]-T2A-GFP construct amplified with
a forward primer encompassing the T7 RNA polymerase
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/advance-article/doi/10.1093/nar/gkaa837/5923428 by U
niversity of East Anglia user on 21 O
ctober 2020
Nucleic Acids Research, 2020 5
promoter upstream of the dCas9 sequence and a reverse
primer with a stop codon and polyA tail designed to the
end of the GFP (primers detailed in Supplementary Ta-
ble S1). The in vitro transcription, DNAseI treatment and
LiCl clean-up were performed following the suppliers rec-
ommendations. The resulting IVT RNA was resuspended
in TE and quantified by spectrophotometer (Nanodrop).
To ensure IVT products were full-length without degra-
dation, an aliquot of IVT RNA was visualized following
gel electrophoresis on a 1.5% agarose gels prepared under
MOPS buffer/formaldehyde denaturing conditions. Em-
bryos were collected from 5 to 7 week-old F1 (C57BL/6J
× CBA/H) super-ovulated females crossed with F1 males.
Superovulation was induced by intraperitoneal injection of
pregnant mare serum gonadotropin (PMSG, Intervet, 5
IU) and human chorionic gonadotropin (hCG, Intervet,
7.5 IU) 46–48 h later. Early zygotes were collected at 18h
hCG injection and microinjected with 1–2pl of 200 ng/l
dCas9-Zfp57[KRAB]-T2A-GFP mRNA, 20 ng/l of cr-
RNA and 20 ng/l of tracrRNA. Embryos were cultured
in K-modified simplex optimized medium microdrops un-
der oil at 37◦C, 5% CO2 for 78 h until the blastocyst stage.
Oocyte and embryo RNA-seq analysis
The single-cell (sc) RNA-seq libraries were generated us-
ing the Nextera XT kits on previously amplified cDNA
(https://doi.org/10.1038/nprot.2014.006). After sequencing,
reads were trimmed using Trim Galore, with a minimal
‘phred’ score for base of 13 and a minimum allowed read
length of 35 bases (as recommended by https://doi.org/10.
1016/j.cell.2015.10.039). Remaining reads were mapped by
Hisat2 against the GRCh38 human genome. Reads were as-
signed to transcripts present in the 94 Ensembl annotation
version of the GRCh38 human genome by using the Rsub-
read R package (https://doi.org/10.1093/nar/gkt214). Cells
with <0.75 million or >10 million assigned reads were fil-
tered out, as well as cells with >7500 detected transcripts.
Transcripts permillion (‘TPM’) normalisationwas also per-
formed. Expression plots for pseudo-merged individual em-
bryos were created using in-house R scripts.
KZNF ChIP-seq data analysis
Public ChIP data was obtained from GEO data series
GSE78099 (12). Files with peaks processed score signals
were retrieved and the data plotted using in-house R scripts.
RESULTS
Characterization of methylation defects in TNDM-MLID
siblings with homozygous ZFP57p.E123*
We previously reported a child with TNDM (II.1), who
we found was homozygous for a one base-pair deletion
(p.E123*) in ZFP57, inheriting the mutations from both
heterozygous parents. Methylation profiling at diagnosis
revealed severe hypomethylation at PLAGL1 and mosaic
LOM at GRB10, NAP1L5 and GNAS-XL DMRs in II.1,
but not in the carrier mother (23) (Figure 1). Ten years
after the first child, a second sibling (II.2) was born with
comparable TNDM and birthweight, but lacked several of
the additional clinical features observed in II.1 (Supplemen-
tary Table S2). Upon molecular investigation this child was
shown to have the same homozygous deletion (Figure 1).
Using the EPIC methylation arrays and bisulphite PCR
with pyrosequencing, we confirmed a hypomethylated sig-
nature similar to the sibling at ubiquitous imprinted DMRs
(Spearman’s correlation rho = 0.85, P = 0), with the ex-
ception of additional hypomethylation at the PEG3 DMR.
(Figure 1; Supplementary Figure S1A; Supplementary Ta-
ble S3).
To further characterise the stability of the imprinting
defects in the two children and understand the potential
role of ZFP57p.E123* in tissue-specific mosaicism, we hy-
bridised buccal-derived DNA and a second leukocyte sam-
ple from II.1 to the EPIC arrays. When comparing the two
blood-derived samples we observed that the hypomethyla-
tion signature is stable over time (Spearman’s correlation
rho = 0.89, P = 0), with the PLAGL1 DMR being the
most severely affected consistent with this being the disease-
causing locus. The two sibling samples differed from the
unaffected mothers sample in their imprinted methylation
profile (Spearman’s correlation rho= 0.53,P= 0). Further-
more, the hypomethylation also occurred in buccal samples,
with the same imprinted DMRs affected to a similar extent
(Spearman’s correlation rho= 0.86, P= 0) (Supplementary
Figure S1A).
Hypomethylation associated with MLID is often par-
tial, with distinct loci subject to varying degrees of LOM.
To understand this mosaic pattern and why some regions
are only partially affected, we generated a lymphoblastoid
cell line following Epstein-Barr virus (EBV) transformation
from the second blood sample of II.1. Initial characteri-
sation upon EBV transformation showed a stable methy-
lation pattern indicating that the immortalization process
had not induced additional changes at imprinted gDMRs
(Supplementary Table S3). We subsequently utilized this
line to generate 28 expanded colonies (<500 cells) derived
from single cells, which we used to characterize imprinted
methylation using a modified SCRAM technique (28) (Fig-
ure 2A, B). This revealed PLAGL1 LOM in 93% (26/28) of
lines, whilst GRB10 hypomethylation was observed in 61%
(17/28) of the lines and in 35% (10/28) and 25% (7/28) for
GNAS-XL andNAP1L5, respectively (Figure 2C). These re-
sults are consistent with the detected levels of mosaicism
observed using the Infinium arrays. Interestingly, while the
lines varied with respect to hypomethylation at GRB10,
GNAS and NAP1L5 varied, we never observed hypomethy-
lation of these loci independent of PLAGL1, and lines with
normal PLAGL1 also had normal methylation at the other
DMRs. Together these results indicate that the methylation
signature associated with recessive mutations of ZFP57 in
humans differ significantly from the equivalent zygotic mu-
tations in mouse.
Determining the histone modification binding preference for
the ZFP57-KAP1 co-repressor complex
One possible explanation why only selected gDMRs are af-
fected when ZFP57 is mutated could be due to preferen-
tial binding to genomic regions with specific patterns of hi-
stone modifications. The TGCCmeGC consensus motif is
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Figure 1. Methylation profiling in a family with TNDM-MLID caused by ZFP57 mutation. (A) Family pedigree with transmission of the ZFP57p.E123*
and examples of the sequence electropherograms showing the mutation in I.1, II.1 and control samples. (B) Analysis of 36 ubiquitously imprinted DMRs
using Infinium HumanMethylationEPIC BeadChip arrays. Methylation differences are color coded according to severity, with blue and red representing
hypo- and hypermethylation, respectively.
present in the human genome >100 000 times, with ∼62%
of these mapping to loci with>75%methylation, yet ChIP-
seq data reveals ∼3000 binding sites (12), of which only se-
lected gDMRs are affected when the gene is mutated. To
determine whether ZFP57 recognises any post-translation
histone modification, adding an additional layer of the
complexity to the recognition of the binding motifs within
gDMRs, we purified HA-ZFP57 and HP1 -HA, a chro-
modomain containing member of the KAP1 co-repressor
complex, from transiently transfected cells and exposed the
proteins separately to MODified™ histone peptide arrays.
These experiments conclusively revealed that ZFP57 is un-
able to directly bind to any histone modification, consistent
with the absence of chromo-domains, whilst HP1 robustly
binds to H3K9me2 and H3K9me3 (Supplementary Figure
S2). This suggests that in addition to direct sequence recog-
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Figure 2. Characterising the level of mosaic methylation through analysis of single cell-derived clones. (A) Schematic overview of the modified SCRAM
technique. (B) Examples of the resulting PCRs for representative colonies. (C) Methylation results for all colonies analysed with the colony ID indicated
and the investigated imprinted DMR labelled on the left.
nition, the ZFP57-KAP1 co-repressor complex associates
with these repressive histone marks, which decorate most
gDMRs, via the recruitment by HP1 .
Human ZFP57 interacts with DNMT3 and KAP1 co-
repressor complex
Previous studies have shown that mouse ZFP57 physi-
cally interacts with DNMT1, DNMT3A/B and KAP1 in
mouse embryonic stem cells (14,15). Since mouse and hu-
man ZFP57 only share 37% amino-acid identify, we wanted
to address whether the human orthologue was able to in-
teract with the KAP1 co-repressor complex. To test this
physical interaction, we generated full-length ZFP57 epi-
tope tagged inducible over-expressing cell lines based on
the T-REx 293 system to overcome the lack of endogenous
expression in cell lines. In ZFP57-myc and KAP1-HA ex-
pressing cells, antibodies against the HA epitope were used
to pull-down KAP1 associated proteins and myc antibody
was used to probe the immunoprecipitated material (Figure
3A). ZFP57-myc was detected when it was over-expressed
with KAP1-HA confirming that these proteins interact
as observed in mice. Similar co-IP experiments revealed
that HP1 -FLAG also interacts physically with ZFP57-
HA in our T-REx 293 cells. Furthermore, FLAG-tagged
DNMT3A and 3B could also interact with ZFP57-HA,
although no co-immunoprecipitation was observed with
DNMT1 indicating that ZFP57 maintains allelic methyla-
tion by recruiting the de novo methyltransferases (Figure
3A).
To determine the effect of theZFP57p.E123*on the recruit-
ment of the KAP1 co-repressor complex, we generated a
truncated version of ZFP57 (FLAG-ZFP57znf) which was
transiently over-expressed with KAP1-HA. We observed
a direct interaction between KAP1 and the ZFP57 mu-
tant lacking all zinc fingers, consistent with the presence
of the intact KRAB domain (Figure 3B). This suggests
that the LOM we observe in our family is due to a fail-
ure of ZFP57p.E123*to binding to DNA. Furthermore, us-
ing site-directed mutagenesis we generated a previous pub-
lished single-base substitution that produces the p.R228H
amino acid change (20). This mutation maps to the third
zinc-finger and has been shown to reduce the ability to
bind methylated DNA (18). This variant also interacts with
KAP1 indicating that theMLID in this patient is not due to
a failure in recruiting the KAP1 co-repressor complex and
is consistent with the observation that the KRAB domain
is the primary mediator of KAP1 interactions (Figure 3B).
This data points towards a reduced recognition for methy-
lated consensus sequences as the potential mechanism be-
hind MLID.
ZFP57-KRAB recruitment is sufficient to protect non-
imprinted germline-derived allelic methylation from epige-
netic reprogramming
We next sought to determine if ZFP57 binding alone is
sufficient to recruit the KAP1 co-repressor complex and
protect non-imprinted oocyte-derived methylation during
pre-implantation development. We hypothesised that the
tethering of ZFP57 to genomic locations that are nor-
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Figure 3. Characterizing in vivo protein-protein interactions for ZFP57 and member of the KAP1 co-repressor complex. (A) Western blotting of co-
immunoprecipitatedmaterial from tetracycline induced ZFP57-HAand transiently transfected interacting partners including epitope taggedKAP1,HP1 ,
DNMT3A, DNMT3B and DNMT1. (B) Co-immunoprecipitation and western blotting for transiently transfected FLAG-ZFP57znf with KAP1-HA and
HA-ZFP57p.R228H with KAP1-V5.
mally methylated in oocytes but reprogrammed very early
in pre-implantation development would be sufficient to
recruit KAP1 co-repressor complex and maintain allelic
DNA methylation. To address this, we generated a dCas9-
Zfp57 fusion construct that lacked the zinc-fingers, but
retained the full KRAB domain in the -C terminus, en-
suring that any DNA targeting was solely due to ribonu-
cleoprotein complex (Figure 4). We validated that our
dCas9-Zfp57[KRAB]-T2A-GFP construct could indeed di-
rectly interact with mouse KAP1-HA in transfected mouse
NIH3T3 cells based on co-IP (Supplementary Figure S3).
To identify specific loci to target, we first interrogated
mouse oocytes and embryo RRBS datasets (31) for re-
gions that were highly methylated in oocytes, lack methy-
lation in sperm and progressively demethylate during pre-
implantation development. We discarded any genes that
presented with a lethal phenotype when knocked-out (ac-
cording to the Mouse Genome Informatics database) as
our manipulations may alter gene dosage in the early em-
bryos. Finally, we selected three different loci, Serpinb6a,
Sgk1 and Tsc22d1, to which we designed two crRNAs on
opposing DNA strands. The specificity of crRNA targeting
was assessed using T7 endonuclease Surveyor assays follow-
ing transfection of Cas9 and tracrRNA into NIH3T3 cells.
All crRNAs were able to target the corresponding regions
and, reassuringly, multiplexing did not affect the target ef-
ficiency at individual loci (Supplementary Figure S3). Sub-
sequently, in vitro transcribed dCas9-Zfp57[KRAB]-T2A-
GFPmRNA,multiplexed crRNAs and tracrRNAwere mi-
croinjected into mouse zygotes. To ensure that any effect
we observed was due to the recruitment of the KRAB do-
main of the dCas9-ZFP57, we also generated a control con-
struct lacking the KRAB effector (dCas9-control) which
we also compared to a non-injected control group (Figure
4A). To control microinjections, we took advantage of the
ATTOTM550 fluorochrome present on the tracrRNA. Em-
bryos which did not display red fluorescence were discarded
from subsequent analyses, while positive embryos were de-
veloped in vitro for 78 h until the blastocyst stage. Indi-
vidual blastocysts were subsequently used for methylation
analysis. We quantified the methylation status of the three
targeted regions by utilizing a nested-multiplex bisulphite
PCR approach coupled with locus-specific pyrosequencing.
To control for amplification bias that may have occurred
because of the high number of PCR cycles, we included
primers for the Airn imprinted gDMR into the nested-
multiplex reaction. Following pyrosequencing we observed
that two loci, Sgk1 and Serpinb6a, retained methylation in
a strand-specific manner upon ZFP57 targeting, suggest-
ing maintenance of oocyte-derived methylation in half of
the injected embryos (Figure 4B, C). Two embryos from the
Tsc22d1 experimental group also had elevated methylation
levels compared to controls (Figure 4B). Interestingly, the
injected embryos that had the highest levels of methylation
were the same, suggesting that the amount of ribonucleo-
protein complex was sufficient to ensure successful target-
ing to their intended loci and recruitment of the KAP1 co-
repressor complex to non-imprinted loci not normally tar-
geted by ZFP57.
Alternative ZFP57 promoter usage originates from a hap-
ASM interval
Mutations of mouse Zfp57 cause the resulting phenotypes
via maternal-zygotic effect and are directly associated with
high oocyte Zfp57 expression, whereas the phenotypes in
humans are only apparent following recessive transmission
and the inheritance of two mutated alleles. To determine
if this species-specific difference in inheritance pattern is
linked to the developmental timing of expression, we de-
termined ZFP57 expression in our RNA-seq datasets from
human oocytes, cleavage embryos and blastocysts. This re-
vealed that human ZFP57 is not expressed in oocytes and
is only detectable at the blastocyst stage (Supplementary
Table S4). Interrogation of the aligned sequences revealed
alternative promoter usage due to the identification of a
unique first exon (NM 001366333.2). This ∼90 bp 5’UTR
sequence is located 4 kb upstream of the first exon of the
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Figure 4. Characterizing the ability of ZFP57 to protect non-imprinted oocyte-derived methylation from epigenetic reprogramming. (A) Schematic repre-
sentation of the dCas9-Zfp57[KRAB]-T2A-GFP construct and the microinjection strategy for mouse zygotes (B) The results of nested-multiplex bisulphite
PCR coupled with locus-specific pyrosequencing for the maternally methylated imprinted control Airn and the targeted loci Serpinb6a, Sgk1 and Tsc22d1.
(C) Confirmation of strand-specific methylation by bisulphite PCR and sub-cloning for the Serpinb6a interval. Each circle represents a single CpG dinu-
cleotide on a DNA strand, a methylated cytosine (•) or an unmethylated cytosine (©).
most prevalent isoform (BC157878) in an interval previ-
ously reported to show haplotype-dependent allele-specific
methylation (hap-ASM) in T-cells (32) (Figure 5A). We
confirm methylation asymmetry between the two alleles in
a heterozygous hES cell line (Val11B), which resulted in
monoallelic expression of ZFP57, but methylation is ab-
sent in gametes and term placenta (Figure 5B, C). Quanti-
tative RT-PCR with exon-spanning primers revealed a sim-
ilar expression profile for both isoforms, indicative of co-
expression in most tissues, being most abundant in spine,
heart, hES cells and placenta (Supplementary Figure S4).
Fascinatingly, the isoform originating from the alternative
promoter results in skipping of exon 2 and a significantly
truncated KRAB domain (Figure 5A).
Temporal expression profiling identifies ZNF202 and
ZNF445 potential imprint factors
Our RNA-seq profiling revealed that human ZFP57 is only
detectable following embryonic-genome activation (EGA)
suggesting that other factors may recruit the KAP1 co-
repressor complex to maintain methylation at imprinted
gDMRs during the cleavage stages of development which
coincided with epigenetic reprogramming. To determine if
other KZFPs could be involved in this process we ques-
tioned whether any of those with available high-resolution
KZFP ChIP-seq maps, could bind to ubiquitously im-
printed DMR. Recently ChIP-seq for 223 KZPs (12), repre-
senting ∼30% of all KZFPs in the human genome has been
reported. The analysis exposed 49 KZFPs binding to dif-
ferent imprinted DMRs, with 25 binding to multiple loci
(Figure 6A; Supplementary Figure S5 and S6). Focusing
on the 25 potential candidates that can bind to multiple
imprinted loci, we next filtered candidates based on their
expressed profile, which we limited to before EGA and the
expression of ZFP57. For this purpose, we re-interrogated
our RNA-seq datasets. Only two KZFPs were highly abun-
dant in oocytes and expressed during the first cleavage divi-
sions; ZNF202 and ZNF445 (Figure 6B). Quantitative RT-
PCR for these two factors revealed ubiquitously expression
in most tissues (Figure 6C). Both genes possess SCANmo-
tifs in the N-terminal domain upstream of their KRAB do-
mains, with ZNF202 having eight zinc fingers and ZNF445
fourteen. Using transient overexpression, ZNF202-FLAG
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Figure 5. Alternative promoter usage and the ZFP57 hap-ASM. (A) Schematic overview of the ZFP57 gene, the location of two transcripts observed in
blastocyst -derived RNA-seq datasets and the position of the hap-ASM. Grey exonic regions indicate the KRAB domain sequences. (B) Characterization
of the allelic expression in Val11B hES cell line andmethylation overlapping the alternativeZFP57 promoter heterozygous for SNP rs3129054 by bisulphite
PCR followed by sub-cloning. Each circle represents a single CpG dinucleotide on a DNA strand, a methylated cytosine (•) or an unmethylated cytosine
(©). (C) Characterisation of monoallelic expression in the Val11B hES cell line.
and ZNF445-HA both interact with KAP1 in co-IP ex-
periments confirming their ability to recruit the KAP1 co-
repressor complex (Figure 6D).
Additional analysis of the high-resolution KZFP ChIP-
seq maps revealed that ZNF202 binds to four imprinted
DMRs (FAM50B, PLAGL1, KCNQ1OT1 and L3MBTL1),
as well as >7000 addition loci throughout the human
genome (12). This implies that ZNF202 has no partic-
ular selectivity for imprinted domains. On the contrary,
ZNF445 binds to 13 different imprinted DMRs (DI-
RAS3, ZDBF2,MEST, PEG13, H19, KCNQ1OT1,MEG3-
DLK1 IG-DMR, MEG3, NNAT, GNAS-NESP, GNAS-
AS1, GNAS-XL and SNU13) out of a total of 638 genome-
wide locations. When comparing these imprinted loci to
those bound by ZFP57, we found that 77% (10/13) are in
common, suggesting these two proteins could work in uni-
son to protect the imprinted regions during early develop-
ment.
Screening MLID cohorts for ZNF202 and ZNF445 muta-
tions
Since very few mutations in epigenetic factors have been di-
rectly associated with MLID, we performed a direct screen
for pathogenic variants that could act via maternal-effect in
ID patients with Beckwith-Wiedemann syndrome (BWS),
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Figure 6. Identification of candidate KZFPs binding to imprinted DMRs. (A) Graphical representation of interactions between KZFP and multiple
imprinted DMRs. White squares indicate a lack of binding, whereas black squares represent a positive ChIP-seq peak located within the defined imprinted
DMR sequence. (B) RNA-seq expression profile for ZNF202, ZNF445 and ZFP57 during human pre-implantation development. (C) Quantitative RT-
PCR showing the distribution of expression for the same three KZFPs across different tissues. (D) Western blotting of co-immunoprecipitations between
FLAG-ZNF202 and HA-ZNF445 with epitope tagged KAP1.
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Pseudohypoparathyroidism type 1B (PHP1B) and TNDM,
along with their mothers. Amplification of ZNF202 and
ZNF445 exons and direct Sanger sequencing of the result-
ing amplicons identified one heterozygous ZNF445 vari-
ant (rs143141433) in the mother of a child with PHP1B
MLID that was not present in 200 controls. This rare mis-
sense variant (1000 genomes 36/5008) results in a p.E957G
amino acid change that was predicted to be benign follow-
ing Polyphen analysis.
DISCUSSION
Multi-locus imprinting disturbances have been observed for
most IDs with varying frequency, often mirroring the inci-
dence of epimutation for each individual disease.Despite in-
tense efforts, the underlying genetic causes have rarely been
identified, with mutations in ZFP57 and members of the
SubCortical Maternal Complex (SCMC) being recurrently
observed in different patient cohorts (20,33–35). Intrigu-
ingly, mutations in ZFP57 are associated with TNDM and
a highly predictable methylation signature (20–23), whereas
there is considerable variability in both clinical presentation
and imprinted loci affected in cases with underlying SCMC
involvement.
In contrast to mouse where ZFP57 maintains allelic
methylation at the majority of gDMRs (14–16), humans are
less dependent on this KZFP. Using extremely rare sam-
ples from a family harbouring a recessive ZFP57 mutation
we investigated the influence of this KZFP on imprinted
gDMRmethylation. We show that the truncating mutation
leads to absolute hypomethylation of PLAGL1 DMR and
varying degrees of LOMat several additional imprinted loci
which is reproducible, not only between tissues of an af-
fected individuals, but stable over time. Furthermore, the af-
fected sibling also had similar aberrant methylation profiles.
The imprinted gDMRs associated with NAP1L5, GRB10
and GNAS presented incomplete LOM in these subjects,
whichwewere able to showwas due to cell mosaicism rather
than allelic partial demethylation.
Studies in mouse models, both in vivo and in mES cells,
have shown that ZFP57 binds to the methylated allele at
gDMRs and recruits the scaffold protein KAP1, the obliga-
tory histone methyltransferase SETDB1 and DNAmethyl-
transferases to deposit H3K9me3 and cytosine methyla-
tion (5mC) at target sequences (13,15). However, it is un-
known whether human ZFP57 recruits these and other
components of the co-repressor complex. Using co-IPs, we
show that human ZFP57 does indeed interact with KAP1,
DNMT3A/B and HP1 . These observations endorse the
model centred around a sequence-specific KZFP recruiting
KAP1, which in turn encourages a self-perpetuating loop
in which SETDB1 deposits H3K9me3 that is recognised
by HP1. Furthermore, since ZFP57 has a strong prefer-
ence for methylated DNA the inclusion of DNMT3s within
the co-repressor complex safeguards the underlying 5mC.
In general, methylation is heritably maintained in somatic
cells by the Uhrf1/Dnmt1 complex that recognizes hemi-
methylated DNA and methylates the newly synthesized un-
methylated daughter strand, protecting against methylation
dilution during each round of DNA replication (36). This
form of maintenance is different to that occurring dur-
ing pre-implantation reprogramming, which is largely de-
pendent upon the sequence-specific recruitment of the co-
repressor complex, which is consistent with our observa-
tions that ZFP57 interacts with the DNMT3A/B and not
DNMT1. Interestingly, both the ZFP57p.E123*deletion and
the non-synonymous p.R228H base substitution retain the
ability to interact with KAP1, suggesting that if present in
the cell of patients, these mutated forms would bind KAP1
butwould not recruit the co-repressor complex to imprinted
gDMRs. Scrutiny of ZFP57 expression in blastocysts iden-
tified an alternative splice isoform that would result in the
translation of a protein lacking the KRAB domain, and
therefore would not have the capacity to recruit KAP1, de-
spite binding to target sequences. Similar isoform struc-
ture has been noted for several additional KZFPs, includ-
ing ZNF74, ZNF468 and ZNF268 (37–39), with competi-
tive repressive action occurring between isoforms, with the
KRAB-containing version responsible for silencing tran-
scription. If this antagonism occurs for ZFP57 in the TE
and placenta, it may result in widespread LOM account-
ing for the polymorphic nature placenta-specific imprinted
gDMRs in humans. More work is required to follow-up on
this hypothesis.
Curiously ChIP-seq data generated in HEK 293 cells by
Imbeault and colleagues reveals that human ZFP57 binds
to several more imprinted gDMRs than are affected in the
TNDMMLID probands (12). One possible reason for such
a discrepancy could be that starker LOM only occurs fol-
lowing maternal-zygotic transmission, such as in mouse,
since most cases in humans are zygotic mutants. However,
this is unlikely, since a TNDMMLID case with a homozy-
gous ZFP57 mutation was born to a homozygous mother,
who herself presented with TNDM at birth. The child had
no evidence of a more severe phenotype nor was the de-
gree of her LOM more severe than other individuals with
ZFP57 mutations (21). An alternative explanation is that
there is compensation by other KZFPs that cooperate to
maintain imprinted gDMRs and that the affected loci in
ZFP57-mutated patients would not be bound by the ad-
ditional KZFPs. Such cooperation between KZFPs is also
supported by the fact that ZFP57 is not expressed dur-
ing the critical time just after fertilization in humans, im-
plying other KZFPs are necessary to initially recruit the
KAP1 co-repressor complex to imprinted gDMRs. Since
our oocyte and embryo RNA-seq datasets confirmed this
notion, we bioinformatically analysed the publicly avail-
able high-resolutionKZFPChIP-seqmaps to identify addi-
tion candidates that bind to imprinted DMRs.Whilst many
KZFPs bind to these genomic intervals, very few are as-
sociated with multiple imprint loci. Furthermore, when we
determined the correct temporal expression in our human
RNA-seq datasets, only two KZFPs were highly abundant
in oocytes with continued expression during cleavage stages
of development, ZNF202 and ZNF445 respectively. Since
ZNF202 only bound to four imprinted DMRs and promis-
cuously binds throughout the genome (12), we focused our
attentions on ZNF445.
Recently Takahashi and co-workers identifiedZNF445 as
a primary regulator of genomic imprinting in mouse (40).
Although maternal-zygotic deletions of Zfp445 in mouse
embryos did not affected imprinted DMRs or allelic ex-
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pression, double homozygous zygotic mutations forZfp445
and Zfp57 gave rise to more remarkable phenotypes associ-
ated with dramatic LOM than either Zfp445 or Zfp57 mu-
tations alone. This led the authors to conclude that murine
imprinted DMRs depend on ZFP445 and ZFP57 to differ-
ent degrees and that these KZFPs act in unison to main-
tain allele-specific imprints in early mouse development.
Our human expression data suggests that rather than act-
ing together during the epigenetic reprogramming window,
these two KZFPs separately recruit the KAP1 co-repressor
complex, ZNF445 initially, followed by ZFP57, since they
are not co-expressed. We speculate that pathogenic muta-
tions in ZNF445 would not be compatible with life, since
a large number of imprinted gDMRs could present with
LOM during early development. However, since individu-
als with biallelic ZFP57 mutations survive (maybe with an
ascertainment bias for those with the DMR signature re-
ported), as do mice carrying targetedZnf445 deletions, mu-
tations inZNF445may have no clinical consequence. To de-
cipher whether mutations of ZNF445 are associated with
developmental phenotypes it may be more appropriate to
screen women with idiopathic infertility or recurrent mis-
carriage in the future.
In conclusion, our studies have identified developmen-
tal and epigenetic discrepancies between the role of ZFP57
in mouse and humans which are due to difference in
the timing of expression during pre-implantation devel-
opment. Screening for additional KZFPs expressed dur-
ing this crucial developmental window identified ZNF445,
which works concurrently with ZFP57 to recruit the KAP1
co-repressor complex in mouse, but unaccompanied imme-
diately following fertilization in humans. Our analysis also
identified other KZFPs with the capacity to bind individual
imprinted gDMRs, suggesting that they may be candidates
for isolated LOMormilder cases ofMLID observed in IDs.
DATA AVAILABILTY
The coordinates of human imprinted gDMRs used in
this are available at www.humanimprints.net. The IIIu-
mina Infinium HumanMethylation450 and HumanMethy-
lationEPIC BeadChip array data has been deposited in
the GEO repository and assigned the accession number
GSE149568. The RNA-seq expression data corresponding
to the oocyte and embryo datasets can be found at NCBI-
BioProject under the accession number PRJNA630371.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We would like to thank the patients and family members
that participated in this study and the clinical staff who
contributed to sample collection. We are grateful to Di-
dier Trono for the mouse KAP1-HA plasmid, and to mem-
bers of the PEBC-IDIBELL, especially Charles Arribas
for performing the methylation array hybridizations, Fer-
nando Setien Baranda for help growing colonies from single
lymphoblastoid cells and Laia Bosch-Presegue´ for advice
regarding native protein extraction used with the MODi-
fied™ histone peptide arrays.
FUNDING
Spanish Ministry of Economy and Competitiveness
(MINECO) [BFU2014-53093-R, BFU2017-85571-R to
D.M.], co-funded with the European Union Regional
Development Fund (FEDER); Research in the GPdN
laboratory is funded partially funded by Instituto de
Salud Carlos III (Institute of Health Carlos III) of the
Spanish Ministry of Economy and Competitiveness,
co-financed by the European Regional Development
Fund [PI16/00073]; Department of Health of the Basque
Government [GV2017/111040]; P.L. and J.T. received
funds from the National Agency of Research (ISCIII-
FEDER) [PI15/01481]; Work in G.K.’s lab is supported
by grants from the UK Medical Research Council
(MRC) [MR/K011332/1, MR/S000437/1]; Biotechnol-
ogy and Biological Sciences Research Council (BBSRC)
[BBS/E/B/000C0423]; A.M.S. is a recipient of an FPI PhD
studentship from MINECO [BES-2015-072547]; EMBO
short-term fellowship to visit in M-ET-P laboratory.
Funding for open access charge: Internal UEA funding.
Conflict of interest statement.None declared.
REFERENCES
1. Monk,D. (2015) Germline-derived DNA methylation and early
embryo epigenetic reprogramming: the selected survival of imprints.
Int. J. Biochem. Cell Biol., 67, 128–138.
2. Monk,D., Mackay,D., J.G.,ET., Maher,E.R. and Riccio,A. (2019)
Genomic imprinting disorders: lessons on how genome, epigenome
and environment interact. Nat. Rev. Genet., 20, 235–248.
3. Ferguson-Smith,A. C. (2011) Genomic imprinting: the emergence of
an epigenetic paradigm. Nat Rev Genet., 12, 565–575.
4. Hanna,C.W., Pen˜aherrera,M.S., Saadeh,H., Andrews,S.,
McFadden,D.E., Kelsey,G. and Robinson,W.P. (2016) Pervasive
polymorphic imprinted methylation in the human placenta. Genome
Res., 26, 756–767.
5. Monk,D. (2015) Genomic imprinting in the human placenta. Am. J.
Obstet. Gynecol., 213, S152–S162.
6. John,R.M. and Lefebvre,L. (2011) Developmental regulation of
somatic imprints. Differentiation, 81, 270–280.
7. Sanli,I. and Feil,R. (2015) Chromatin mechanisms in the
developmental control of imprinted gene expression. Int. J. Biochem.
Cell Biol., 67, 139–147.
8. Inoue,A., Jiang,L., Lu,F., Suzuki,T. and Zhang,Y. (2017) Maternal
H3K27me3 controls DNA methylation-independent imprinting.
Nature, 547, 419–424.
9. Hanna,C.W., Pe´rez-Palacios,R., Gahurova,L., Schubert,M.,
Krueger,F., Biggins,L., Andrews,S., Colome´-Tatche´,M.,
Bourc’his,D., Dean,W. et al. (2019) Endogenous retroviral insertions
drive non-canonical imprinting in extra-embryonic tissues. Genome
Biol., 20, 225.
10. Chen,Z., Yin,Q., Inoue,A., Zhang,C. and Zhang,Y. (2019) Allelic
H3K27me3 to allelic DNA methylation switch maintains
noncanonical imprinting in extraembryonic cells. Sci. Adv., 5,
eaay7246.
11. Urrutia,R. (2003) KRAB-containing zinc-finger repressor proteins.
Genome Biol., 4, 231.
12. Imbeault,M., Helleboid,P.Y. and Trono,D. (2017) KRAB zinc-finger
proteins contribute to the evolution of gene regulatory networks.
Nature, 543, 550–554.
13. Schultz,D.C., Ayyanathan,K., Negorev,D., Maul,G.G. and
Rauscher,F.J. 3rd. (2002) SETDB1: a novel KAP-1-associated histone
H3, lysine 9-specific methyltransferase that contributes to
HP1-mediated silencing of euchromatic genes by KRAB zinc-finger
proteins. Genes Dev., 16, 919–932.
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/advance-article/doi/10.1093/nar/gkaa837/5923428 by U
niversity of East Anglia user on 21 O
ctober 2020
14 Nucleic Acids Research, 2020
14. Li,X., Ito,M., Zhou,F., Youngson,N., Zuo,X., Leder,P. and
Ferguson-Smith,A.C. (2008) A maternal-zygotic effect gene, Zfp57,
maintains both maternal and paternal imprints. Dev. Cell, 15,
547–557.
15. Quenneville,S., Verde,G., Corsinotti,A., Kapopoulou,A.,
Jakobsson,J., Offner,S., Baglivo,I., Pedone,P.V., Grimaldi,G.,
Riccio,A. et al. (2011) In embryonic stem cells, ZFP57/KAP1
recognize a methylated hexanucleotide to affect chromatin and DNA
methylation of imprinting control regions.Mol. Cell, 44, 361–372.
16. Takahashi,N., Gray,D., Strogantsev,R., Noon,A., Delahaye,C.,
Skarnes,W.C., Tate,P.H. and Ferguson-Smith,A.C. (2015) ZFP57 and
the targeted maintenance of postfertilization genomic imprints. Cold
Spring Harb. Symp. Quant. Biol., 80, 177–187.
17. Shi,H., Strogantsev,R., Takahashi,N., Kazachenka,A.,
Lorincz,M.C., Hemberger,M. and Ferguson-Smith,A.C. (2019)
ZFP57 regulation of transposable elements and gene expression
within and beyond imprinted domains. Epigenetics Chromatin, 12, 49.
18. Baglivo,I., Esposito,S., De Cesare,L., Sparago,A., Anvar,Z., Riso,V.,
Cammisa,M., Fattorusso,R., Grimaldi,G., Riccio,A. et al. (2013)
Genetic and epigenetic mutations affect the DNA binding capability
of human ZFP57 in transient neonatal diabetes type 1. FEBS Lett.,
587, 1474–1481.
19. Strogantsev,R., Krueger,F., Yamazawa,K., Shi,H., Gould,P.,
Goldman-Roberts,M., McEwen,K., Sun,B., Pedersen,R. and
Ferguson-Smith,A.C. (2015) Allele-specific binding of ZFP57 in the
epigenetic regulation of imprinted and non-imprinted monoallelic
expression. Genome Biol., 16, 112.
20. Mackay,D.J., Callaway,J.L., Marks,S.M., White,H.E., Acerini,C.L.,
Boonen,S.E., Dayanikli,P., Firth,H.V., Goodship,J.A., Haemers,A.P.
et al. (2008) Hypomethylation of multiple imprinted loci in
individuals with transient neonatal diabetes is associated with
mutations in ZFP57. Nat. Genet., 40, 949–951.
21. Boonen,S.E., Mackay,D.J., Hahnemann,J.M., Docherty,L.,
Grønskov,K., Lehmann,A., Larsen,L.G., Haemers,A.P.,
Kockaerts,Y., Doomsm,L. et al. (2013) Transient neonatal diabetes,
ZFP57, and hypomethylation of multiple imprinted loci: a detailed
follow-up. Diabetes Care., 36, 505–512.
22. Touati,A., Errea-Dorronsoro,J., Nouri,S., Halleb,Y., Pereda,A.,
Mahdhaoui,N., Ghith,A., Saad,A., Perez de Nanclares,G. and
H’mida Ben Brahim,D. (2019) Transient neonatal diabetes mellitus
and hypomethylation at additional imprinted loci: novel ZFP57
mutation and review on the literature. Acta Diabetol., 56, 301–307.
23. Court,F., Martin-Trujillo,A., Romanelli,V., Garin,I.,
Iglesias-Platas,I., Salafsky,I., Guitart,M., Perez de Nanclares,G.,
Lapunzina,P. and Monk,D. (2013) Genome-wide allelic methylation
analysis reveals disease-specific susceptibility to multiple methylation
defects in imprinting syndromes. Hum. Mutat., 34, 595–602.
24. Sa´nchez,A.M., Delgado,M.S., Ciurana,S.G., Medrano,J.,
Poo-Llanillo,M.E., Ishida,M., Moore,G.E., Platas,I.I., Simo´n,C. and
Monk,D. (2018) Epigenetic symmetry of DLGAP2: pre-implantation
maternal methylation switches to a random monoallelic profile in
somatic tissues. OBM Genetics, 2, 026.
25. Hernandez Mora,J.R., Tayama,C., Sa´nchez-Delgado,M.,
Monteagudo-Sa´nchez,A., Hata,K., Ogata,T., Medrano,J.,
Poo-Llanillo,M.E., Simo´n,C., Moran,S. et al. (2018) Characterization
of parent-of-origin methylation using the Illumina Infinium
MethylationEPIC array platform. Epigenomics, 10, 941–954.
26. Court,F., Tayama,C., Romanelli,V., Martin-Trujillo,A.,
Iglesias-Platas,I., Okamura,K., Sugahara,N., Simo´n,C., Moore,H.,
Harness,J.V. et al. (2014) Genome-wide parent-of-origin DNA
methylation analysis reveals the intricacies of human imprinting and
suggests a germline methylation-independent mechanism of
establishment. Genome Res., 24, 554–569.
27. Sanchez-Delgado,M., Court,F., Vidal,E., Medrano,J.,
Monteagudo-Sa´nchez,A., Martin-Trujillo,A., Tayama,C.,
Iglesias-Platas,I., Kondova,I., Bontrop,R. et al. (2016) Human
Oocyte-Derived methylation differences persist in the placenta
revealing widespread transient imprinting. PLos Genet., 12, e1006427.
28. Cheow,L.F., Quake,S.R., Burkholder,W.F. and Messerschmidt,D.M.
(2015) Multiplexed locus-specific analysis of DNA methylation in
single cells. Nat. Protoc., 10, 619–631.
29. Lo´pez-Abad,M., Iglesias-Platas,I. and Monk,D. (2016) Epigenetic
characterization of CDKN1C in placenta samples from
non-syndromic intrauterine growth restriction. Front. Genet., 7, 62.
30. Kabadi,A.M., Ousterout,D.G., Hilton,I.B. and Gersbach,C.A. (2014)
Multiplex CRISPR/Cas9-based genome engineering from a single
lentiviral vector. Nucleic. Acids. Res., 42, e147.
31. Smith,Z.D., Chan,M.M., Mikkelsen,T.S., Gu,H., Gnirke,A.,
Regev,A. and Meissner,A. (2012) A unique regulatory phase of DNA
methylation in the early mammalian embryo. Nature, 484, 339–344.
32. Do,C., Lang,C.F., Lin,J., Darbary,H., Krupska,I., Gaba,A.,
Petukhova,L., Vonsattel,J.P., Gallagher,M.P., Goland,R.S. et al.
(2016) Mechanisms and disease Associations of haplotype-dependent
allele-specific DNA methylation. Am. J. Hum. Genet., 98, 934–955.
33. Docherty,L.E., Rezwan,F.I., Poole,R.L., Turner,C.L., Kivuva,E.,
Maher,E.R., Smithson,S.F., Hamilton-Shield,J.P., Patalan,M.,
Gizewska,M. et al. (2015) Mutations in NLRP5 are associated with
reproductive wastage and multilocus imprinting disorders in humans.
Nat. Commun., 6, 8086.
34. Begemann,M., Rezwan,F.I., Beygo,J., Docherty,L.E., Kolarova,J.,
Schroeder,C., Buiting,K., Chokkalingam,K., Degenhardt,F.,
Wakeling,E.L. et al. (2018) Maternal variants in NLRP and other
maternal effect proteins are associated with multilocus imprinting
disturbance in offspring. J. Med. Genet., 55, 497–504.
35. Sparago,A., Verma,A., Patricelli,M.G., Pignata,L., Russo,S.,
Calzari,L., De Francesco,N., Del Prete,R., Palumbo,O., Carella,M.
et al. (2019) The phenotypic variations of multi-locus imprinting
disturbances associated with maternal-effect variants of NLRP5
range from overt imprinting disorder to apparently healthy
phenotype. Clin Epigenetics, 11, 190.
36. Sharif,J., Muto,M., Takebayashi,S., Suetake,I., Iwamatsu,A.,
Endo,T., Shinga,J., Mizutani-Koseki,T.T., Okamura,K. et al. (2007)
The SRA protein Np95 mediate epigenetic inheritance by recruiting
Dnm1 to methylated DNA. Nature, 450, 908–912.
37. Coˆte´,F., Boisvert,F.M., Grondin,B., Bazinet,M., Goodyer,C.G.,
Bazett-Jones,D.P. and Aubry,M. (2001) Alternative promoter usage
and splicing of ZNF74 multifinger gene produce protein isoforms
with a different repressor activity and nuclear partitioning. DNA Cell
Biol., 20, 159–173.
38. Sun,L., Gu,S., Li,N., Zheng,D., Sun,Y., Li,D., Ji,C., Ying,K., Xie,Y.
and Mao,Y. (2005) A novel zinc finger gene ZNF468 with two
co-expressional splice variants, ZNF468.1 and ZNF468.2. Biochem.
Genet., 43, 271–286.
39. Shao,H., Zhu,C., Zhao,Z., Guo,M., Qiu,H., Liu,H., Wang,D.,
Xue,L., Gao,L., Sun,C. et al. (2006) KRAB-containing zinc finger
gene ZNF268 encodes multiple alternatively spliced isoforms that
contain transcription regulatory domains. Int. J. Mol. Med., 18,
457–463.
40. Takahashi,N., Coluccio,A., Thorball,C.W., Planet,E., Shi,H.,
Offner,S., Turelli,P., Imbeault,M., Ferguson-Smith,A.C. and
Trono,D. (2019) ZNF445 is a primary regulator of genomic
imprinting. Genes Dev., 33, 49–54.
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/advance-article/doi/10.1093/nar/gkaa837/5923428 by U
niversity of East Anglia user on 21 O
ctober 2020
